Article Versions Notes

Gelsomino F, Casadei-Gardini A, Rossini D, Boccaccino A, Masi G, Cremolini C, Spallanzani A, Viola MG, Garajovà I, Salati M, et al. The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis. Cancers. 2020; 12(4):1022. https://doi.org/10.3390/cancers12041022

Gelsomino, Fabio, Andrea Casadei-Gardini, Daniele Rossini, Alessandra Boccaccino, Gianluca Masi, Chiara Cremolini, Andrea Spallanzani, Massimo Giuseppe Viola, Ingrid Garajovà, Massimiliano Salati, and et al. 2020. "The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis" Cancers 12, no. 4: 1022. https://doi.org/10.3390/cancers12041022

Gelsomino, F., Casadei-Gardini, A., Rossini, D., Boccaccino, A., Masi, G., Cremolini, C., Spallanzani, A., Viola, M. G., Garajovà, I., Salati, M., Elia, M. T., Caputo, F., Santini, C., Falcone, A., Cascinu, S., & Tamburini, E. (2020). The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis. Cancers, 12(4), 1022. https://doi.org/10.3390/cancers12041022